Abnormalities in GRPR-triggered signaling have been described inboth fibroblasts from patients with AD, and in transgenic mouse models of AD.Pharmacological and genetic preclinical studies have indicated that BLPs and theGRPR are importantly involved in regulating cognitive function. The gene discussed is GRPR; the disease is Alzheimer disease.